Micronutrient status assessment in humans:Current methods of analysis and future trends by Holler, Ulrich et al.
  
 University of Groningen
Micronutrient status assessment in humans
Holler, Ulrich; Bakker, Stephan J. L.; Dusterloh, Andre; Frei, Balz; Koehrle, Josef; Konz,
Tobias; Lietz, Georg; McCann, Adrian; Michels, Alexander J.; Molloy, Anne M.
Published in:
TrAC-Trends in Analytical Chemistry
DOI:
10.1016/j.trac.2018.02.001
IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Final author's version (accepted by publisher, after peer review)
Publication date:
2018
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Holler, U., Bakker, S. J. L., Dusterloh, A., Frei, B., Koehrle, J., Konz, T., ... Rezzi, S. (2018). Micronutrient
status assessment in humans: Current methods of analysis and future trends. TrAC-Trends in Analytical
Chemistry, 102, 110-122. https://doi.org/10.1016/j.trac.2018.02.001
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 21-05-2020
290118 revised submission TrAC 
~ 1 ~ 
 
Micronutrient status assessment in humans: Current methods of analysis and future trends 1 
 2 
Ulrich Höllera*, Stephan JL Bakkerb, Andre Düsterloha, Balz Freic, Josef Köhrled, Tobias Konze, Georg Lietzf, 3 
Adrian McCanng1, Alexander J Michelsc, Anne M Molloyh, Hitoshi Murakamii, Dietrich Reinj2, Wim HM Sarisk, 4 
Karlheinz Schmidtl, Kazutaka Shimboi, Soeren Schumacherm, Cees Vermeern, Jim Kapute3, Peter Webera, 5 
Manfred Eggersdorfera, Serge Rezzie* 6 
 7 
a DSM Nutritional Products, Research & Development, Analytical Research Center, and Nutrition, Science 8 
& Advocacy, Kaiseraugst, Switzerland 9 
b University Medical Center Groningen, University of Groningen, Groningen, The Netherlands 10 
c Linus Pauling Institute, Oregon State University, Corvallis, Oregon, USA 11 
d Charité University Hospital, Berlin, Germany 12 
e Nestle Institute of Health Sciences, Lausanne, Switzerland 13 
f University of Newcastle, Newcastle upon Tyne, UK 14 
g University of Ulster, Coleraine, U.K. 15 
h School of Medicine, Trinity College Dublin, Ireland 16 
i Ajinomoto Co Inc, Tokyo, Japan 17 
j Metanomics Health GmbH, Berlin, Germany 18 
k Department of Human Biology, NUTRIM School of Nutrition and Translational Research in Metabolism, 19 
Maastricht University Medical Centre + (MUMC+), The Netherlands 20 
l University of Tübingen, Germany 21 
m Fraunhofer Institute for Biomedical Engineering, Potsdam, Germany 22 
n VitaK, Maastricht University, The Netherlands 23 
 24 
1 Current addresses: 1 Bevital AS, Bergen, Norway; 2 BASF SE, Lampertheim, Germany; 3 Vydiant Inc, Gold 25 
River, California 26 
 27 
290118 revised submission TrAC 
~ 2 ~ 
 
*Correspondence: Ulrich Hoeller, Tel: +41 61 815 8845, Email: ulrich.hoeller@dsm.com; Serge Rezzi, Tel: 28 




Micronutrients are essential to health at every life stage and their deficiencies are associated with 33 
increased incidence of various pathophysiological states and poor quality of life. Efficient methods are 34 
therefore needed to monitor micronutrient status of individuals and to improve evidenced-based 35 
recommendations for populations. This review (i) reports current approaches to assess the vitamin and 36 
mineral status in humans, (ii) summarizes current analytical advantages and shortcomings and (iii) provides 37 
practical information for both nutrition research and nutritional status diagnostics. Future analytical 38 







Vitamins and other micronutrients provide the foundations for optimal human nutrition and long-term health. 46 
Quantitative assessment of micronutrients is used to diagnose deficiencies or excess, as well as to establish dietary 47 
guidelines by regulatory agencies, e.g., the United States Food & Drug Administration (FDA). Micronutrients can be 48 
quantitatively measured in various biological matrices such as blood, urine, saliva, cells, hair, and nails. Given the 49 
long history of the effects of nutritional deficiencies and insufficiencies on health and over 100 years of research, 50 
important knowledge gaps remain on how to measure the status of several micronutrients efficiently and accurately. 51 
A lack of scientific consensus also exists on whether micronutrient functional markers could substitute for classical 52 
status markers to assess deficiencies or insufficiencies. More efforts are required to discover and validate novel 53 
functional markers that complement established status markers (i.e. indicative of specific micronutrient body stores) 54 
for the general population, specific patient groups, and ultimately individuals. 55 
 56 
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The current pandemics of non-communicable diseases such as type 2 diabetes, obesity, and cardiovascular disease 57 
associate with specific micronutrient deficiencies and/or insufficiencies, and paradoxically in some cases, 58 
overnutrition. The multifactorial characteristics of non-communicable diseases and the inherent intricacy of the 59 
absorption and activities of micronutrients from complex mixtures of food and beverages require a shift of the 60 
research paradigm from a reductionist, single-nutrient approach to studying multiple nutrients simultaneously at the 61 
system level. Nutritional management of health in future will increasingly integrate holistic micronutrient profiling 62 
with individual specific lifestyle and dietary habits. At a time when postgenomic analytics, including proteomics and 63 
metabolomics, have enabled comprehensive molecular phenotyping of humans, the field of micronutrient analysis 64 
continues to use relatively classic methodologies. A portfolio of methods is used which range from simple 65 
immunoassays to more sophisticated high-performance liquid chromatography coupled to -tandem mass spectrometry 66 
(HPLC-MS/MS) techniques1,2. These methods analyze (usually) a single or limited number of micronutrient entities at 67 
once. The limited throughput analysis has a direct impact on cost and required sample volumes for complete 68 
micronutrient status analysis. However, recent advances in chromatographic and mass-spectroscopy techniques offer 69 
a broad range of solutions to revisit the field of micronutrient status analysis. This review describes current markers 70 
and methodologies for the analysis of biologically important micronutrients, i.e. vitamins and minerals, in humans. 71 
A structured overview of the biological background of selected micronutrients, current status- or functional markers 72 
is provided, with the corresponding analytical methodologies, highlighting advantages and limitations. We also 73 
introduce technological perspectives related to quantitative profiling approaches, sensitivity challenges and 74 
miniaturized technologies for nutritional status analysis. 75 
 76 
 77 
Water-soluble vitamins 78 
 79 
B vitamins 80 
The B vitamin group consists of water-soluble organic molecules that act as cofactors for many metabolic and 81 
physiologic functions3,4.  82 
 83 
Thiamine (vitamin B1)  84 
Thiamine has a central role in the metabolism of carbohydrates, branched-chain amino acids and fatty acids. 85 
Thiamine occurs in the body in free and phosphorylated forms (mono-, di-, tri-phosphate and adenosine thiamine 86 
triphosphate (AThTP). Thiamine diphosphate (TDP) is the biologically active form acting as a coenzyme for, e.g., 87 
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pyruvate dehydrogenase, α-ketoglutarate dehydrogenase, branched-chain α-ketoacid dehydrogenase complex and 88 
transketolase (TK). TDP is required for reactions in mitochondrial oxidative decarboxylation, pentose phosphate 89 
pathway and citric acid cycle5. In mammalian tissues, the concentration of thiamine triphosphate (TTP) is regulated 90 
by a specific thiamine triphosphatase6 but knowledge gaps remain on the actual role of this functional vitamin analog. 91 
Body stores of thiamine are limited and deficiency usually occurs within 2-3 weeks of cessation of intake. Thiamine 92 
status is typically determined by measuring the thiamine dependent erythrocyte transketolase activity (ETKA), or 93 
alternatively thiamin (free or phosphorylated) concentrations. The ETKA assay provides a functional assessment of 94 
thiamin deficiencies by measuring the relative increase of erythrocyte transketolase activity in response to in vitro 95 
addition of TDP. Currently, this method is the most accepted for assessing thiamine deficiency although analytical 96 
variability is reported due to standardization and sample stability issues4,7. HPLC-based methods to quantify free 97 
thiamine, thiamine monophosphate (TMP), total thiamine (free thiamine + TMP), TDP and TTP in plasma, erythrocytes 98 
and whole blood have also been developed with the premise of providing a more sensitive and specific index of 99 
thiamine intake and status relative to ETKA7. HPLC analysis of TDP in whole blood or erythrocytes relies on 100 
fluorescence detection which requires pre- or post-column conversion of thiamine to thiochrome7. This method 101 
although sensitive requires further improvements related to inter-laboratory standardization and throughput8. 102 
 103 
Riboflavin (vitamin B2) 104 
Vitamin B2 is involved in redox reactions and antioxidant functions, metabolism of other B vitamins (B3, B6, B9) and 105 
energy production9. Intracellular metabolism involves phosphorylation of riboflavin to form the cofactors flavin 106 
mononucleotide (FMN) and flavin adenine dinucleotide (FAD), which account for most of riboflavin in plasma and 107 
tissues. FAD acts as cofactor for enzymes such as methylenetetrahydrofolate reductase (MTHFR) and the erythrocyte 108 
enzyme glutathione reductase (GR), while pyridoxine phosphate oxidase (PPO), which converts dietary vitamin B6 to 109 
the biologically active form pyridoxal 5´-phosphate, is dependent on FMN9. Riboflavin status is often assessed by a 110 
functional test, the erythrocyte glutathione reductase activity coefficient (EGRac) assay9. The coefficient is 111 
calculated as the ratio between flavin-dependent GR activity in washed red blood cells (RBC) before and after in 112 
vitro stimulation with FAD. The ratio of FAD-stimulated to unstimulated enzyme activity indicates the degree of 113 
tissue saturation with riboflavin10. EGRac values and dietary intake of riboflavin are highly correlated making it a 114 
well-accepted riboflavin functional marker4. However, the method requires fresh erythrocytes and proper inter-115 
laboratory standardization. The EGRac method may be less reliable under certain conditions including β-thalassemia, 116 
slow conversion of riboflavin to FMN and FAD in erythrocytes, and glucose-6-phosphate dehydrogenase deficiency4. 117 
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Hustad et al. compared EGRac with measures of free riboflavin and the coenzymes FAD and FMN analyzed directly in 118 
serum/plasma or homogenized erythrocytes using liquid chromatography coupled to tandem mass spectrometry (LC-119 
MS/MS)11. Plasma and erythrocyte FMN and FAD, EGRac and plasma riboflavin were found to correlate, and all B2 120 
vitamers, except for plasma FAD, were deemed suitable for the assessment of vitamin B2 status in population studies. 121 
 122 
Niacin (Vitamin B3) 123 
Metabolism of carbohydrates and lipids depends on niacin (pyridine-3-carboxylic acid or nicotinic acid, NA, and 124 
nicotinamide). NA is metabolized to nicotinuric acid (NUA) through nicotinyl–CoA by glycine conjugation or to 125 
nicotinamide (NAM). NAM is further metabolized to N1-methyl nicotinamide (MNAM), nicotinamide-N-oxide (NAMO), 126 
and then methylated and/or oxidized to N-methyl-2-pyridone-5-carboxamide (2-Py, the major metabolite) and N-127 
methyl-4-pyridone-5-carboxamide (4-Py). The pyridines are the end products of nicotinamide metabolism in 128 
mammals4. 129 
Niacin and derivatives are measured by a variety of methods including gas chromatography (GC), HPLC using UV- or 130 
fluorometric detection, and mass spectrometry (MS) (reviewed in12). LC-MS/MS allows for simultaneous quantification 131 
of NA, NAM, NUA and 2-Py from human plasma collected in K2EDTA (ethylenediaminetetraacetic acid dipotassium 132 
salt) blood tubes12. 133 
Niacin and seven of its metabolites (NAM, MNAM, NAMO, 2-Py, 4-Py, NUA, and trigonelline) can also be measured in 134 
urine using supercritical fluid chromatography (SFC) coupled to MS13. Several studies involving small numbers of 135 
subjects have been published providing ranges of niacin-derived metabolites in the urine4. Most of niacin in the urine 136 
is in the form of NMN (20–35 %) and 2-Py (35–60 %) and these ranges are due to interindividual variability in 137 
metabolizing niacin metabolites and dietary intake of the parent compounds and tryptophan, a metabolic precursor14. 138 
 139 
Pantothenic acid (vitamin B5) 140 
Pantothenic acid, as indicated by its name, is widespread in nature and occurs in the food chain mainly as part of 141 
Coenzyme A (CoA) and its derivative, acetyl-CoA. The amount bound in acyl carrier protein (ACP), as opposed to free 142 
pantothenic acid itself, significantly contributes to whole body status of this cofactor. Deficiency is rare in the general 143 
population, which explains the relatively few analytical methods and studies published for assessment of pantothenic 144 
acid status compared to other vitamins. While blood plasma is used to determine body status, urinary excretion is a 145 
measure of pantothenic acid uptake4. Early assays use pantothenic acid dependent micro-organisms such as 146 
Lactobacillus plantarum for quantification4. Since these assays may be prone to nonspecific interference, more 147 
specific radioimmunoassay (RIA) and enzyme-linked immunosorbent assay (ELISA) tests have been developed4. 148 
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Analysis with GC or HPLC coupled to MS detection requires  prior sample treatment with pantetheinase, which is not 149 
well suited for high-throughput analysis15. As isotopically labeled pantothenic acid is readily available from 150 
pantolactone and [13C3
15N]-β-alanine15, and hence HPLC-MS/MS analysis has become more widespread, especially in 151 
clinical laboratories. Analysis in blood and urine has been reviewed recently in detail16. 152 
 153 
Vitamin B6 154 
Vitamin B6 is a generic term that refers to six interconvertible compounds, pyridoxine, pyridoxamine (PM), and 155 
pyridoxal (PL), and their phosphorylated derivatives pyridoxine 5´-phosphate (PNP), pyridoxamine 5´-phosphate 156 
(PMP), and pyridoxal 5´-phosphate (PLP). PLP is the active form, which serves as cofactor in more than 50 enzymatic 157 
functions, including transamination, α-decarboxylation, β- and γ-elimination reactions. PLP-dependent enzymes play 158 
a vital role in amino acid biosynthesis and degradation, the metabolism of immune-modulating compounds and 159 
neurotransmitters, as well as organic acids, glucose, sphingolipids, and fatty acids. 160 
Concentration of vitamin B6 forms measured in circulation or urine are typically used to indicate vitamin B6 status, 161 
with plasma PLP being the most commonly used parameter4. The concentrations of plasma PL, 4-pyridoxic acid (PA), 162 
and PLP, may provide additional information on vitamin B6 distribution and homeostasis
4. For instance, plasma PL 163 
may serve as a surrogate marker of intracellular PLP17. PA is associated with markers of cellular immune activation 164 
but not acute-phase inflammation18. Erythrocyte PLP has been proposed as a more appropriate marker of vitamin B6 165 
status than plasma PLP. Erythrocyte PLP, plasma PLP, PL, PA, and urinary PA excretion are responsive to vitamin B6 166 
depletion, repletion and supplementation17,19,20. 167 
Since the interpretation of individual B-vitamers may be confounded by ongoing biological processes of different 168 
physiological states, ratios between closely related metabolites may provide better insight into status. For example, 169 
the PA:(PLP + PL) ratio, termed PAr, has demonstrated particular value as a marker of inflammation induced vitamin 170 
B6 catabolism
21. 171 
Functional biomarkers of vitamin B6 status based on traditional methods such as erythrocyte aminotransferase activity 172 
or the tryptophan-loading test are now rarely used due to practical challenges and standardization difficulties. The 173 
development of analytical capabilities, utilizing LC- and GC-MS/MS, has created the possibility of quantifying 174 
numerous amino acids and metabolites related to PLP-dependent pathways simultaneously. The metabolites of the 175 
kynurenine pathway and substrate-product ratios such as 3-hydroxykynurenine (HK): xanthurenic acid (XA) and HK:3-176 
hydroxyanthranilic acid (HAA) have been evaluated as markers of vitamin B6 status
22. The diminished or negligible 177 
influence of confounders such as inflammation, body mass index (BMI), and kidney function on kynurenine metabolite 178 
ratios22 further supports the use of such metabolite ratios. 179 
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 180 
Biotin (vitamin B7) 181 
Dietary biotin occurs naturally as either free or protein bound forms, the latter involving a covalent binding of the 182 
vitamin to polypeptide lysine residues. The protein bound form is degraded by digestive enzymes into biocytin that 183 
is further cleaved by biotinidase into free biotin and lysine. The intracellular biotin pool consists of enzymes-bound 184 
and free fractions, to either act as cofactor or for posttranslational protein biotinylation, respectively. Several 185 
enzymes requiring biotin (e.g. acetyl CoA-, pyruvate-, methylcrotonyl- and propionyl carboxylases) play key roles in 186 
the intermediary metabolism related to fatty acid synthesis, gluconeogenesis, amino acid catabolism and the citric 187 
acid cycle. 188 
Biotin deficiency can result from insufficient dietary intake, inborn errors of biotin metabolism, specific drug intake 189 
and pregnancy23. Biotin status analysis can be measured using different methods including microbiological, GC, avidin 190 
binding, colorimetric, polarographic and isotope dilution assays4. Applications include analysis of either plasma or 191 
urine samples. No clear consensus has been reached on the best analytical approach for biotin status assessment. 192 
The most commonly accepted analysis is of urinary biotin and 3-hydroxyisovaleric acid. The performance of several 193 
markers of biotin status has been examined in a randomized cross-over study designed to create states of deficiency, 194 
sufficiency, and supplementation in sixteen healthy men and women24. The authors concluded that the quantification 195 
of biotinylated methylcrotonyl-CoA and propionyl-CoA carboxylases in lymphocytes were the most reliable markers 196 
of biotin status. Alternatively, the quantification of plasma 3-hydroxyisovaleryl carnitine, a metabolite resulting from 197 
decreased methylcrotonyl-CoA activity and impaired leucine catabolic pathway, by HPLC-MS/MS has been proposed 198 
as a potential marker of biotin status although further clinical validation is needed25. 199 
 200 
Folate (vitamin B9) 201 
The B vitamins folate (B9) and cobalamin (B12) jointly participate in one-carbon metabolism and thus have close 202 
biological links4. Both are usually measured concurrently, since deficiency of one will interact with blood status 203 
markers of the other. Active forms of folates consist of a parent molecule, tetrahydrofolate (THF), and its one-carbon 204 
derivatives, including formyl- (CHO), methylene- (CH2), methenyl- (CH=), methyl- (CH3) and formimino- (NHCH) 205 
groups covalently bonded to the N5 or N10 position of the pteroyl residue. These different cofactors can be further 206 
modified within cells by the addition of between 6 and 8 glutamate residues to the parent molecule. 207 
Most analytical procedures measure the monoglutamate form and thus a polyglutamate hydrolysis step is usually 208 
required prior to quantification. Both serum and RBC folate provide relevant and complimentary clinical and 209 
nutritional information. Serum/plasma folate is regarded as a good indicator of recent folate status and is used as a 210 
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first-line clinical indicator of folate deficiency. 5-methylTHF monoglutamate is the predominant natural folate form 211 
in serum4. The RBC folate content is regarded as a good indicator of longer-term tissue status and has been extensively 212 
used both in nutritional population and clinical studies. In addition, RBC folate species can vary depending on common 213 
folate-related polymorphisms such as the methylene tetrahydrofolate reductase (MTHFR) 677CT polymorphism, 214 
and genetic variations may affect the affinity of binding proteins used in some analytical methodologies26. These 215 
unmeasured cofounders in RBC folate analysis are known to contribute to large inter-laboratory and inter-method 216 
differences27. 217 
Folates can be measured using HPLC-MS/MS, electrochemical, or fluorescence based techniques as well as with radio- 218 
and immuno-based assays and the traditional Lactobacillus casei growth assay28. This microbiological approach 219 
measures all biologically active folate species, including di- and tri-glutamates of the species, but cannot 220 
differentiate between the species. The specificity of protein binding assays to measure 5-methylTHF in RBCs is limited 221 
by variations in residual polyglutamate length, and variations in the concentration of non-methylTHF species in RBCs, 222 
as noted above. Thus, LC-MS/MS is the methodology of choice and is expected to become the gold-standard method 223 
for folate status assessment29,30. Use of reference standards and proficiency-testing schemes are needed for a better 224 
comparison of folate status across populations. 225 
 226 
 227 
Vitamin B12 228 
Vitamin B12 comprises a group of cobalt-containing corrinoids also referring to cobalamins, the latter term being used 229 
for the biologically active cofactor. The vitamin was first crystallized as cyanocobalamin, the form technically known 230 
as vitamin B12. Two mammalian apoenzymes, methylmalonyl CoA mutase and methionine synthase, need cobalamin 231 
as cofactor, in the forms of 5’deoxyadenosyl- and methyl-cobalamin, respectively. Methionine synthase catalyzes the 232 
transfer of a methyl group from 5-methylTHF to the cofactor cobalamin intermediate and then to homocysteine. This 233 
is a key step in the one-carbon cycle which produces methionine and THF. 234 
Vitamin B12 is bound to transcobalamin (TC) and haptocorrin (HC) for transport in the blood, with about 20 % being 235 
attached to TC and the rest to HC. However, only TC-bound cobalamin is actively transported into tissues and is 236 
therefore suggested to be a more relevant marker of vitamin B12 status. 237 
Historically, vitamin B12 was measured using microbiological assays such as the Lactobacillus delbrueckii method 238 
which was later adapted for high-throughput use4. Measurement of the total vitamin B12 concentration in serum is 239 
the first-line clinical test for determination of vitamin B12 deficiency. The current assays are mostly based on 240 
competitive binding of the serum vitamin to intrinsic factor, followed by radiometric or fluorescence-based 241 
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detection. A newer method estimates holotranscobalamin (holoTC) as a fraction of vitamin B12 carried by TC in serum 242 
and therefore available for tissue uptake. This assay is currently being evaluated in many clinical laboratories, and 243 
reports to date suggest that holoTC is a more reliable marker of tissue vitamin B12 status than serum total vitamin 244 
B12
31. 245 
Two metabolite markers, methylmalonic acid (MMA) and homocysteine (Hcy), are also assessed routinely. MMA is 246 
derived from methylmalonyl-CoA, a substrate of the mutase enzyme that uses cobalamin as cofactor. Low serum MMA 247 
concentrations indicate normal status, whereas in vitamin B12 deficiency the concentration rises sharply. Similarly, 248 
an increase in the total plasma Hcy concentration is also indicative of vitamin B12 deficiency since it reflects impaired 249 
function of the methionine synthase reaction. However, Hcy is not specific for vitamin B12 since it is also elevated in 250 
folate or vitamin B6 deficiency. Furthermore, interpretation of either biomarker can be biased by confounding factors 251 
including impaired renal function, dietary intake, and genetic variation. Although holoTC appears as the most reliable 252 
vitamin B12 status marker, more research and clinical validation is required to reach consensus on how to assess this 253 
vitamin status in general population and patient groups. Speciation analysis of the different cobalamin forms (i.e. 254 
methyl-, hydroxyl-, cyano-, and adenosyl-cobalamin) by HPLC coupled to inductively-coupled plasma mass 255 
spectrometry (ICP-MS) could be developed as an alternative approach for vitamin B12 status. Nevertheless, such 256 
analysis in biological fluids remains challenging due to the endogenous concentrations of the different cobalamin 257 
forms at the picomolar range.  258 
 259 
Vitamin C 260 
Vitamin C (ascorbic acid) is a strong reducing agent that when oxidized generates dehydroascorbic acid and 261 
subsequently 2,3-diketo-L-gulonic acid. To minimize the loss of vitamin C through oxidation, metabolism, or excretion, 262 
physiological systems have evolved an ascorbate recycling mechanism implying a rapid reduction of dehydroascorbic 263 
acid to ascorbate in the intracellular environment by glutathione or the selenoenzyme thioredoxin reductase.  264 
In addition to antioxidant roles, ascorbic acid participates in a variety of enzymatic reactions, especially α-265 
ketoglutarate dioxegenases that are involved in such diverse roles as response to hypoxia, deoxyribonucleic acid (DNA) 266 
hydroxymethylation, collagen maturation, and carnitine synthesis32. These enzymatic functions underlie scurvy 267 
symptomology that is the result of vitamin C deficiency. Furthermore, vitamin C plays also key roles in the 268 
homeostasis of iron metabolism4. 269 
Several biological compartments such as whole blood, erythrocytes, leucocytes, and plasma or serum can be used to 270 
assess vitamin C status. However, serum or plasma concentrations are the most reliable marker, as tissue 271 
concentrations are typically used to infer sufficiency in cells, tissues, and other biological fluids. Analysis of ascorbic 272 
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acid in biological samples is complicated by the high susceptibility of this compound to oxidation. Methods for 273 
stabilization of ascorbic acid after sample collection are often critical to achieve reliable quantification. Ascorbic 274 
acid is preserved at low pH (typically, concentrated meta-phosphoric or perchloric acid solutions) and reducing agents 275 
such as dithiothreitol (DTT) or tris(2-carboxyethyl)phosphine (TCEP), followed by immediate analysis or storage 276 
(usually -70°C or -80°C)4,33. The addition of reducing agents precludes the analysis of native dehydroascorbic acid 277 
concentrations, but these are not considered relevant for the assessment of whole body vitamin C status. 278 
Alternatively, small amounts of EDTA can effectively prevent oxidation of ascorbic acid. The chelating agent acts by 279 
complexing divalent minerals ions such as copper which can no longer form metal–oxygen–ascorbate complexes, which 280 
are diradical intermediates in the oxidation of vitamin C to dehydroascorbic acid. Several approaches have been 281 
developed to measure vitamin C in biological materials including spectrophotometric, fluorometric, electrochemical 282 
and liquid chromatography methods4. HPLC using either ion-exchange or reverse phase columns coupled to 283 
spectrophotometrical, electrochemical and ultraviolet detection, provides an efficient means to quantify vitamin C 284 
with good selectivity and sensitivity34. 285 
 286 
 287 
Fat-soluble vitamins 288 
 289 
Vitamin A and provitamin A carotenoids 290 
Vitamin A refers to all compounds with vitamin A activity, but only retinol and its fatty acid esters are considered 291 
relevant for determining vitamin A status in humans. Night blindness and impaired dark vision adaptation are typical 292 
clinical signs of xerophthalmia, and can be assessed as a functional marker of clinical vitamin A deficiency35. 293 
Xerophthalmia responds within hours to days after high-potency vitamin A treatment. Plasma retinol is probably the 294 
most analyzed biochemical indicator for determining vitamin A deficiency, defined as plasma retinol concentrations 295 
< 0.7 µmol/L36. However, plasma retinol is not a sensitive indicator of vitamin A status in individuals since the plasma 296 
concentration is under strict homeostatic control36 and is depressed during infection and inflammation35. Pro-297 
vitamin A carotenoids contain one unsubstituted β-ionone ring and also contribute to retinol status. The most 298 
important pro-vitamin A carotenoid is β-carotene, followed by β-cryptoxanthin, α-carotene and γ-carotene. The 299 
biological activity of these compounds relative to retinol is estimated to be in the order of 50% for β-carotene and 300 
25% for carotenoids with only one β-ionone end group37. 301 
Retinol can be measured using dried blood spots (DBS), providing the ability to collect small blood samples under 302 
field conditions with limited infrastructure38. Although this approach has therefore received considerable attention 303 
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as vitamin A status test in remote areas, stability issues limit the widespread practical application38. The retinol-304 
binding protein (RBP), an independent measure of vitamin A concentration, has shown good sensitivity and specificity 305 
for predicting vitamin A deficiency under field conditions for 2–6 weeks after DBS collection. However, RBP is 306 
depressed during Zn deficiency and inflammation, and could also be affected by kidney disease and obesity, 307 
decreasing its utility as surrogate marker for vitamin A deficiency35. HPLC coupled with UV, diode array or 308 
fluorescence detection is used to measure retinol concentrations in plasma4. The retinol metabolites retinal and 309 
retinoic acid as well as further related oxidation products can be quantified down to the femtomolar level in serum, 310 
tissue, and chylomicrons by LC-MS/MS methods39,40. 311 
Carotenoids are mainly assessed from plasma using HPLC coupled to visible spectrophotometry. The distinct color 312 
and high molar absorption coefficient of these compounds make this detection competitive to MS/MS detection with 313 
regard to sensitivity and specificity with the benefit of avoiding the use of isotopically labeled standards41. 314 
The retinol isotope dilution technique (RID) can assess total body stores of vitamin A, detect quantitative changes in 315 
response to interventions, and can be used to determine the efficacy of pro-vitamin A food-based interventions42. 316 
The RID method is based on the oral administration of a small dose of tracer-labeled vitamin A followed by the 317 
determination of the tracer, either 2H or 13C, to unlabeled vitamin A (as a ratio) in plasma using mass spectrometry. 318 
Most current methods involve extensive and time-consuming extraction/purification procedures. However, a recent, 319 
highly sensitive LC-MS/MS analytical method employed a one-phase extraction that did not require additional 320 
processing and allowed separation of labeled β-carotene, retinol, retinyl acetate, retinyl linoleate, retinyl 321 
palmitate/retinyl oleate, and retinyl stearate within a 7-minute runtime43. 322 
Regardless of the technology for measuring retinol, a combination of biochemical analyses with model-based 323 
compartmental analysis allow quantification of the exchangeable total-body vitamin A in human subjects after oral 324 
administration of stable isotopes44. More importantly, using a single equation and a single blood sample 4-5 day after 325 
administering labeled vitamin A provides a good estimate of individual total body vitamin A stores, thus overcoming 326 
the major drawback of large inter-individual variability of tissue vitamin A concentration and status45. 327 
 328 
Vitamin D 329 
Vitamin D encompasses vitamin D3 (cholecalciferol) and vitamin D2 (ergocalciferol). In the body, vitamin D undergoes 330 
successive metabolic hydroxylation into 25-hydroxy-vitamin D and 1,25-dihydroxy-vitamin D in the liver and kidney, 331 
respectively. Vitamin D is essential for bone development and maintenance, and plays an important role in innate 332 
immunity. More than 50 additional metabolites have been described to date. The discovery of the 3-epimer of 25-333 
OH-vitamin D, particularly relevant in infants, and its contribution to the vitamin D concentrations in adults illustrates 334 
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the complexity of the vitamin D metabolic network4. The first hydroxylation product of vitamin D, 25-OH-vitamin D 335 
is recognized as the best status marker. Since the body does not store 25-OH-vitamin D, the concentration in 336 
circulation (plasma or serum) can be used for status determination. Recently the free (not protein bound) circulating 337 
25-OH-vitamin D3 was used as measure of the bioavailable vitamin D
46. It can be assessed either directly or can be 338 
calculated from total 25-OH-vitamin D3, vitamin D binding protein and human serum albumin (HSA) concentrations. 339 
Both competitive chemiluminescence immunoassays and HPLC-MS/MS assays are used in clinical practice and the pros 340 
and cons of both technologies have been reviewed in depth47. The varying selectivity of the antibodies for 25-OH-341 
vitamin D2 and 25-OH-vitamin D3 and potential for cross-reactivity with related metabolites such as 24,25-dihydroxy-342 
vitamin D impact the repeatability between different immune-based assays. Thus, HPLC-MS/MS is currently regarded 343 
as the gold standard for vitamin D status assessment. HPLC-MS/MS methods enable fast separation and quantification 344 
of 25-OH-vitamin D2 and 25-OH-vitamin D3 and additional metabolites in a single run. Derivatization with Cookson-345 
type reagents prior to LC-MS/MS, although adding an additional step in the sample preparation, can further increase 346 
the sensitivity, allowing the quantification of 1,25-(OH)2-vitamin D3 at nanomolar concentrations
48. The Vitamin D 347 
External Quality Scheme (DEQAS) and the U.S. National Institute of Standards and Technology (NIST) developed 348 
reference standards and qualification procedures for vitamin D analysis. Results from DEQAS are published on a 349 
regular base, and reveal significant variation of assay performance. 350 
Vitamin D is stable at room temperature on dried blood spots and was one of the first vitamins analyzed with this 351 
sampling method49. Derivatization followed by LC-MS/MS analysis even enables the concurrent quantification of 352 
additional metabolites such as the 3α and 3β epimers of 25-OH-vitamin D3
50. The recent application of this 353 
methodology in the Food4Me nutritional study with nearly 1500 participants showed its suitability for application 354 
even with unsupervised sampling by the participants at home51. The possibility of assessing vitamin D status non-355 
invasively from saliva was investigated52, although more data will be needed to establish full equivalence to blood 356 
testing. Moreover, miniaturized immuno-based assays show good premises for future point of care determination of 357 
vitamin D status53. 358 
 359 
Vitamin E 360 
Vitamin E encompasses eight naturally occurring vitamers - 4 tocopherols and 4 tocotrienols. Only α-tocopherol is 361 
routinely measured and used for status determination since this form is preferably maintained in circulation4. In 362 
contrast to α-tocopherol, the seven other vitamers are not recognized by the α-tocopherol transfer protein (α-TTP) 363 
in the liver. In addition to the liver, α-tocopherol is also stored to some extent in adipose tissue. The main function 364 
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of α-tocopherol is to act as reducing partner in redox reactions involving lipids. Polyunsaturated fatty acids are 365 
protected from peroxidation, especially in the cell membranes54. 366 
Since body stores and membrane content of vitamin E are difficult to assess, the concentration in circulation is used 367 
for status determination. α-Tocopherol is prominently associated with circulating lipid fractions, and therefore often 368 
reported relative to total lipids, LDL-cholesterol or triglycerides4. While total lipids are considered to be the best 369 
marker, total cholesterol is used in practice because it is easily and routinely measured. 370 
α-Tocopherol concentrations in plasma allow quantification by HPLC with fluorescence or UV detection4. Using 371 
normal-phase HPLC, tocopherols and tocotrienols can also be separated. A recently introduced fast and sensitive 372 
reversed-phase HPLC method resolves the challenging separation of β- and γ-tocopherol55. Separation and 373 
quantification of the eight stereoisomers of α-tocopherol is much more challenging. While the four 2R-isomers can 374 
readily be separated by chiral-phase HPLC, e.g., as their acetates using Chiralcel OD56, an efficient analysis of the 375 
four 2S-isomers still must be developed. Current methodologies require quantitative preparation and isolation of the 376 
respective acetates, followed by conversion to their methyl ethers, and GC separation with a runtime of more than 377 
2 hours56. 378 
Further research into functional markers for vitamin E status could lead to target compounds or assay systems that 379 
would have more potential for point-of-care applications. Examples include the measurement of products of lipid 380 
peroxidation such as 4-hydroxynonenal, malondialdehyde, or pentane as indicator of vitamin E status57. While some 381 
correlations to α-tocopherol status have been established, these compounds need further validation to be accepted 382 
as reference markers. So far, cell activity assays based on measuring hemolysis of erythrocytes under oxidative stress4 383 
and urinary α-carboxyethyl hydroxychroman (α-CEHC) appear as promising functional markers for α-tocopherol58. 384 
 385 
Vitamin K 386 
Vitamin K is a name for a family of compounds including phylloquinone (vitamin K1) from plant based foods and the 387 
menaquinones (different molecules which are referred to as vitamin K2) from carnivorous and bacterial sources. The 388 
nomenclature uses MK-n, where n stands for the number of isoprenoid residues in the aliphatic side chain. 389 
Physiologically important forms of vitamin K are K1, MK-4, MK-7, MK-8, MK-9 and MK-10
59. The various forms have 390 
very different pharmacokinetics with half-life of 1-2 hours for MK-4 and K1 and 3 days or more for MK-7 and longer 391 
chain MKs60. 392 
Vitamin K is reduced in the cell to form vitamin K hydroquinone and serves as a cofactor for the endoplasmic enzyme 393 
γ-glutamate carboxylase (GGCX), which converts sequence-specific glutamate residues into γ-carboxyglutamate (Gla) 394 
in a post-translational carboxylation reaction4. Different vitamers exhibit different cofactor activities. Vitamin K 395 
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insufficiency causes incomplete protein carboxylation and hence leads to sub-optimal Gla-protein activity which in 396 
turn results in impaired blood clotting. 397 
Human vitamin K status may be assessed by measuring the circulating concentration of each of the relevant vitamers 398 
or by measuring the circulating concentration of uncarboxylated Gla-proteins4. Direct measurement of circulating K-399 
vitamers is generally accomplished by reversed phase HPLC or ultra-performance liquid chromatography (UPLC) with 400 
fluorescence or mass spectrometric detection61,62. Unfortunately, many menaquinones are not available as reference 401 
compounds preventing their accurate analysis by MS. In addition, the concentration in circulation reflects recent 402 
dietary exposure rather than true status concentrations. Nevertheless, the level of response to dietary intake has 403 
been suggested to estimate vitamin K status63. The Vitamin K external quality assurance scheme (KEQAS) has been 404 
created to harmonize vitamin K1 measures across laboratories with reference samples. Similar to several other 405 
vitamins, the relationship between circulating and tissue vitamin K concentrations is not well established, limiting 406 
the ability to assess vitamin K body status. ELISA-based methods for measuring uncarboxylated Gla-proteins are 407 
currently the most reliable for assessing vitamin K status. These are direct and functional assays that assess tissue-408 
specific proteins including descarboxy-prothrombin (PIVKA) for liver, uncarboxylated osteocalcin (ucOC) for bone, 409 
and circulating desphospho-uncarboxylated matrix Gla-protein (dp-ucMGP) for the arterial vessel wall64. Many of 410 




Iron, copper, zinc, selenium, iodine and manganese are essential micronutrients involved in multiple biological 415 
processes including energy production, oxido-reduction reactions, signal transduction, electrolyte balance, structure 416 
of proteins and enzymatic catalysis4. Depending on the mineral, status measurements are performed by measuring 417 
either the total amount of the element or a related biomolecule, mainly proteins. 418 
 419 
Iron (Fe) 420 
Fe is an integral component of heme, a cofactor of hemoglobin and myoglobin that occur in blood and muscle, 421 
respectively. In addition, iron-sulfur clusters (mainly 4Fe-4S and 2Fe-2S) are essential for the mitochondrial 422 
respiratory chain in the cells. Fe homeostasis is controlled by a complex molecular system that regulates uptake, 423 
storage, and mobilization4. Dietary Fe is transported from the small intestine into the enterocytes as Fe2+ by a divalent 424 
metal transport protein 1 (DMT1) or as heme-iron through a receptor mediated endocytosis mediated by the heme 425 
carrier protein 1 (HCP1). Fe is then released by ferroportin (FPN1)65 into circulation where it complexes as Fe3+ with 426 
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the transporting protein transferrin. Fe status can be measured using different markers and matrices including blood 427 
serum, plasma and bone marrow. Since it is correlated with the total body Fe stores, the concentration of serum 428 
ferritin is a marker of choice for the diagnosis of both Fe deficiency and overload. Serum ferritin analysis can be 429 
performed by immunoturbidimetry, nephelometry, and electro-chemiluminescence immunoassay, each method 430 
differing in sensitivity and selectivity. Since ferritin is an acute phase protein, its use for Fe status analysis is affected 431 
by inflammation. Assessment of Fe status can be improved by measuring the blood soluble transferrin receptor (sTfR), 432 
an inflammation insensitive marker, by nephelometry. sTfR originates from proteolysis of the TfR on the surface of 433 
erythroblasts and quantification of sTfR reflects Fe demand for erythropoiesis. Both ferritin and sTfR can be combined 434 
in the sTfR/log ferritin ratio, i.e.. the sTfR Index, which was proposed as a better estimate of Fe status66. Recent 435 
evidence suggests that hepcidin-25, a peptide hormone acting as a main regulator of human Fe homeostasis, may be 436 
a reliable status marker for Fe status67 pending proper clinical validation. Several quantitative methodologies for 437 
hepcidin have been developed in different biological fluids including immunoassay and MS68. 438 
 439 
Copper (Cu) 440 
Cu is an essential mineral that is part of the catalytic centers of enzymes such as ceruloplasmin (Cp), hephaestin, 441 
cytochrome c oxidase (CCO) and Cu-Zn superoxide dismutase (SOD). Cu is involved in iron- and energy metabolism as 442 
well as in antioxidant defense systems. Cu is absorbed as Cu+ through a specific transporter (CTR1 or SLC31A1) located 443 
in the enterocytes and circulates in serum as Cu bounded to albumin, transcuprein, and ceruloplasmin69. Cu status is 444 
mainly determined by its serum total concentration, ceruloplasmin or by the functional test of Cu/Zn SOD activity4. 445 
Each method has limitations due to lack of standardization and high inter-individual variability70. These markers can 446 
also be confounded by inflammation, pregnancy, lifestyle (smoking), as well as by physiological conditions linked to 447 
aging and pathological conditions (hypertension, cirrhosis, and cancer). Alternative biomarkers of Cu status have 448 
been evaluated but with limited success4.  449 
 450 
Zinc (Zn) 451 
Zn is involved in many biochemical reactions acting as enzyme catalyst (e.g., Cu-Zn SOD) and structural conformation 452 
element (Zn finger transcription proteins)4. Zn is absorbed in the small intestine by a class of specific transporters 453 
(ZnT and Zip)71. Intracellular Zn transport is ensured by a family of cysteine-rich proteins (e.g. metallothioneins)72. 454 
In blood, Zn is predominantly transported via binding to serum albumin and alpha-2-macroglobulin, which accounts 455 
for only 0.1 % of the total body Zn, the vast majority of Zn being located in the skeletal muscle, bone, liver and skin 456 
cells73. Despite the high prevalence of Zn deficiency, the assessment of its status still lacks a well-accepted biomarker. 457 
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So far, serum or plasma total Zn concentrations are accepted as status markers, with demonstrated response to both 458 
supplementation and depletion4. Urinary Zn excretion is also considered a useful indicator of Zn status due to its 459 
collinear response to either Zn supplementation or depletion74. Total Zn concentration can be quantified using atomic 460 
absorption spectrometry (AAS), inductively-coupled plasma optical emission spectroscopy (ICP-OES) and ICP-MS. 461 
Surrogate indicators of Zn status including number of platelets, polymorpho- and mononuclear cells, as well as 462 
erythrocyte Zn content and plasma alkaline phosphatase activity have also been considered but with limited clinical 463 
acceptance4. Alternatively, a new series of markers such as erythrocyte metallothioneins, plasma extracellular 464 
superoxide dismutase, expression of Zn transporter ZIP1 mRNA in lymphocytes and Zn-regulated low-molecular-465 
weight humoral factor are being developed. 466 
 467 
Selenium (Se) 468 
Se is centrally involved in the intra- and extracellular redox-regulation and participates in antioxidant defense 469 
systems through glutathione peroxidase- (GPx) catalyzed reduction of hydrogen peroxides4, where selenocysteine 470 
forms part of the enzyme catalytic site. In the enterocytes, dietary Se absorption occurs either via selenite (SeO3
2−) 471 
or selenate (SeO4
2–) salts or as organic compounds such as Se-Cysteine and Se-Methionine using multifunctional anion 472 
exchanger (Na+-sulfate transporters)75 and specific amino acids transporters such as the b0,+rBAT system, 473 
respectively76. Once absorbed, Se is enzymatically converted into selenide (H2Se), the precursor for selenoprotein 474 
biosynthesis. In the liver, Se is then incorporated into selenoprotein P (SePP) that is released in the circulation as the 475 
major circulating Se-containing molecule. Se status is determined using the serum concentration of total Se (mainly 476 
indicating short-term status) and SePP77. Serum Se concentration is affected by lifestyle (smoking, alcohol intake) 477 
and inflammation. Analysis of total Se can be performed using atomic spectroscopic techniques such as AAS and ICP-478 
MS or total X-ray reflection spectroscopy whereas ELISA assays are available for SePP. The erythrocyte Se 479 
concentration has been proposed as an alternative Se status biomarker that would be less confounded by acute-phase 480 
response78 and more indicative of mid- to long-term Se status. Long-term Se status can also be assessed using 481 
measurement of GPx activity in erythrocytes79,80. 482 
 483 
Iodine (I) 484 
Iodine is key to the function of the thyroid gland where it is involved in the synthesis of the hormones thyroxine (T4) 485 
and triiodothyronine (T3) which contain four and three I atoms, respectively. Thyroxine plays a pivotal regulatory 486 
role for brain development and the basal metabolic rate and also promotes bone growth by interacting with the 487 
growth hormone (GH)81. Dietary I is readily absorbed by the enterocytes as iodide (I-) by a sodium-iodide symporter 488 
290118 revised submission TrAC 
~ 17 ~ 
 
(NIS)82. The level of expression of NIS is modulated by the circulating concentration of iodide and by thyroid-489 
stimulating hormone (TSH)83. I status is determined by measuring concentrations of I in urine or concentration of TSH 490 
and thyroglobulin (Tg) in serum4. Evaluation of the goiter rate is also used to assess I deficiency. Serum concentration 491 
of TSH is an indicator of I status particularly in infancy. However, I intake and serum TSH concentration exhibits a U-492 
shaped relationship and both too low and too high nutritional I intake result in elevated serum TSH concentrations84. 493 
Serum quantification of Tg, the precursor of T3 and T4 hormones, is more responsive to dietary iodine and can be 494 
seen as a mid-term biomarker of I status85. Both serum TSH and Tg concentrations can be measured by immunoassays. 495 
Urinary iodine (UI) concentration is a valuable indicator of short-term I status. Indeed, more than 90% of dietary 496 
iodine is excreted in urine and urinary I concentration changes rapidly in response to dietary I intake. Total I in 24 h 497 
urine is considered the most reliable status marker although spot urine samples are also used in epidemiological 498 
studies with normalization to creatinine excretion4. Urinary I is measured by a kinetic-colorimetric assay based on 499 
the Sandell-Kolthoff reaction or by ICP-MS4. Long-term I deficiency can be inferred by the clinical examination of a 500 
goiter by palpation or by ultrasonography86. However, these methods lack sensitivity, specificity and can be 501 
confounded by several I-independent pathophysiologies. 502 
 503 
Manganese (Mn) 504 
Manganese is an essential trace element for humans. Mn is cofactor for Mn-dependent SOD2 (mitochondrial form), 505 
pyruvate carboxylase and arginase and is involved in neurological-, immune-, antioxidant and energy metabolism87. 506 
Mn homeostasis is tightly controlled at the levels of intestinal absorption, tissue uptake and excretion to prevent 507 
deficiency and accumulation, the latter potentially causing cellular oxidative damage87. Mn and Fe metabolism are 508 
closely intertwined since both metals share uptake and transport pathways. Alike Fe2+, Mn2+ enters the small intestine 509 
enterocytes mainly through DMT1. Mn2+ is exported from the cells through FPN1 followed by an oxidation into Mn3+ 510 
mediated by ceruloplasmin. In circulation, Mn3+ is mainly bound to proteins such as transferrin and HSA and 511 
transported to tissues where uptake is mediated by several transport mechanisms, including DMT1 and the transferrin 512 
receptor87. Mn nutritional status is mainly assessed by its elemental quantitation in blood serum, urine or hair samples 513 
using atomic spectroscopy or elemental MS techniques. However, several studies demonstrate partial response of 514 
serum concentrations to Mn supplementation. While urinary Mn excretion is indicative of depletion, Mn determination 515 
in hair has limited value for status assessment4. The analysis of SOD2 concentration in peripheral blood mononuclear 516 
cells using immunoassay is foreseen to provide a Mn functional marker although lacking clinical validation4.  517 
 518 
Current trends and future perspectives 519 
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Vitamins and mineral status analyses are fundamental for nutritional status assessment. A large variety of 520 
methodologies for vitamin and mineral measurement have been developed over decades, targeting either single 521 
molecules or a reduced set of analytes. The development of quantitative profiling methods for the analysis of multiple 522 
vitamins remains a challenging task. Indeed, the intrinsic physical properties of vitamins (i.e. water- or fat-soluble 523 
molecules) imply the need for different sample preparation and analysis protocols. Furthermore, several vitamins 524 
are prone to rapid degradation due to oxygen, light and temperature. High heterogeneity exists in terms of molecular 525 
structures and concentration range (from µM to pM range) within each group of vitamins (e.g. B group vitamins). 526 
These analytical difficulties have contributed to a highly fragmented landscape of available methodologies that often 527 
lack validation and inter-laboratory standardization. In addition, the high number of micronutrient-specific methods 528 
has hampered the possibility to investigate nutrient-nutrient interactions and the influence of genetic, environment 529 
(including diet), and disease factors. Analytical sensitivity, cost and sample volume requirements of the various assays 530 
are further limitations. However, recent technological improvements of chromatography and mass spectrometry open 531 
new possibilities to perform high throughput micronutrient quantitative profiling in biological matrices88. Recently, 532 
a method was developed and validated for the quantification of a set of 14 liposoluble vitamins and carotenoids in a 533 
single run of 8 min from 200 L of human blood plasma using a combination of supported liquid extraction and 534 
ultrahigh-performance supercritical fluid chromatography coupled to tandem mass spectrometry89. Another work 535 
reports the analysis of twenty-one water soluble vitamins by LC-MS/MS from 200 L of plasma in less than 15 minutes90. 536 
Related to mineral status analysis, the recent introduction of inductively-coupled plasma coupled to tandem mass 537 
spectrometry (ICP-MS/MS) has enabled the simultaneousquantification of 29 elements from 150 L of human blood 538 
serum with high accuracy and precision91. Hence, profiling of multiple vitamin forms and minerals is now possible 539 
with significantly improved analytical throughputs. Such analytical progress will continue to enhance the field of 540 
micronutrient analysis with novel profiling-derived biomarker patterns that can capture absorbed and biologically 541 
active forms and their downstream metabolites with the lowest possible number of analytical methods. Continuous 542 
developments of chromatography and mass spectrometry techniques will be key to ensure quantitation of structurally 543 
similar molecules and efficient resolution of isobaric interferences47,92. High resolution MS techniques will add full 544 
scan screening capabilities to the already popular isotopic dilution MS/MS solutions in the clinical assessment of 545 
micronutrient status and functions47. Furthermore, new methods able to differentiate speciation forms as well as 546 
isotopic signatures93,94 of minerals could be developed to deliver complementary information on the metabolic fate 547 
of elements in biological systems. Technological developments are also expected on miniaturization of both pre-548 
analytics (e.g. sample collection and transport) and analytics of micronutrients. DBS solutions95 and volumetric 549 
absorptive microsampling (VAMS)96 were developed to provide easier and faster sample processing relatively to 550 
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conventional venipuncture procedures. Technical challenges with these microsampling methods include the 551 
variability of the hematocrit content, and specifically to DBS, the accurate determination of the analyzed volume. 552 
These micro-sampling solutions are convenient in terms of cost and ease of shipment to central analytical laboratories. 553 
Usually, around 10 L whole blood is collected, thereby challenging the sensitivity limits of analytical techniques 554 
such as MS. If one considers the recently developed micronutrient quantitative profiling methods89,91, transfer to DBS 555 
or VAMS will result in the loss of almost half of quantifiable micronutrients with the current sensitivity limits. While 556 
more efficient sampling systems such as nano-infusion techniques are being developed, MS sensitivity will still have 557 
to increase by 100% to warrant the measure of the same analytical panels as in plasma or serum samples. However, 558 
should such method transfer to DBS or VAMS be developed, it will be essential to properly assess micronutrient 559 
stability on these sample collection devices since several vitamins are prone to rapid degradation due to light 560 
exposure and temperature. 561 
As an alternative to central laboratory-based testing, the concept of point of need analysis holds promise to benefit 562 
micronutrient analysis with integrated, miniaturized, reliable and cost-effective measurement devices to enable 563 
personalized nutrition97. Of the current routine methods, immuno-based assays can be miniaturized in a compelling 564 
way and are fast enough to cope with these needs. Nano-array approaches of nano-Molecular Imprinted Polymers and 565 
aptamers that recognize and assess multiple micronutrients are also being developed98. Other technologies, most 566 
prominently using sensor enhanced electrochemistry, could assess many biologically active molecules in real time99. 567 
Moreover, it will be interesting to evaluate alternative body specimens such as saliva, sweat, hairs and breath for 568 
the minimally invasive analysis of several micronutrient status or functional markers. However, the use of these 569 
biological matrices will have to be scientifically and clinically proven of relevance in micronutrient status analysis. 570 
While promising, the general use of these new technologies would require proper methodology validation including 571 
the establishment of the equivalence of analytical performance with traditional blood assays in large population 572 
trials. Carotenoid status determination, thanks to the unique spectroscopic properties of these molecules, provides 573 
an interesting example of non-invasive analysis. Total carotenoids can indeed be assessed using RAMAN 574 
spectroscopy100, and macular pigment optical density (MOPD) determination is now available to assess lutein contents 575 
in the retina101. 576 
 577 
Methodologies for micronutrient assessment are thus constantly revisited and improved towards more comprehensive 578 
profiling approaches. However, several technological and clinical challenges remain ahead for the implementation 579 
of fully validated solutions for nutrition and health management.  580 
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- achieve high levels of sensitivity to enable measurement of nutritional status in different biological 581 
compartments (blood plasma/serum, cells, and urine) and with miniaturized sample collection devices; 582 
- quantify nutrients and micronutrients and their metabolic products to generate next generation of status and 583 
functional biomarkers; 584 
- capture a broad range of molecules that reflect the inherent complexity of the nutritional exposome, 585 
nutrient-nutrient interactions and their effect on human health using a minimal set of analytical approaches; 586 
- develop appropriate reference materials for quality control and proceed with a thorough validation of 587 
profiling methods to decrease inter-assay and -laboratory variabilities to ensure harmonization and data 588 
comparability; 589 
- enable analysis of micronutrient status at point-of-need for real-time nutritional recommendations. 590 
Should these technical challenges be efficiently overcome, future micronutrient analytics (i.e. micronutrient profiling 591 
and point-of-need devices) are foreseen to integrate with people’s specific lifestyle and diet components into a 592 
holistic health management approach.   593 
 594 
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Table 1: Markers and methods for status determination of water-soluble vitamins; for details cf. the respective section in the text.  
  Vitamin B1 Vitamin B2  Vitamin B3 
(Niacin) 
 Vitamin B5 
(Pantothenic 
acid) 

























































































Whole blood Plasma or 
serum 
Urine Serum and 
whole blood 






                                                          
1 All matrices are derived from venous blood, typically 100 µL or less are required for analysis; except for vitamin C no fasting is required prior to sampling. 
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cell folate is 
required. 




                                                          
2 Concentrations for initial guidance, not meant as reference range4. 
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Table 2: Markers and methods for status determination of fat-soluble vitamins; for details cf. the respective section in the text. 
  Vitamin A Pro-vitamin A 
carotenoids 
Vitamin D Vitamin E Vitamin K 
Best marker Total body store of 
vitamin A using 
stable isotopes 
Carotenoids 25-hydroxy vitamin D 
(D2+D3) 
α-tocopherol ratio to 
total blood lipids 
Uncarboxylated Gla-
proteins.  





State of the art 
methodology 







Matrix3  Plasma or serum Plasma or serum Plasma or serum Plasma or serum For PIVKA: citrated 
plasma  



















1.58 µg/L (plasma 
PIVKA), 3.3±0.4 µg/L 
(plasma uc-
osteocalcin) 
                                                          
3 All matrices are derived from venous blood, typically 100 µL or less are required for analysis; for vitamins A, E and K and ß-carotene fasting is preferred prior to sampling. 
4 Concentrations for initial guidance, not meant as reference range4. 
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Gaps / issues Non-invasive 
alternatives via 
blood spots, isotope 
test dose not always 
at physiological 
concentration 
Quantification of cis 
isomers; bioactivity 






Requires analysis of 
lipids or cholesterol 
for referencing 
Food composition 






values (DRV) and 
recommended daily 
allowance (RDA) for 
extrahepatic 
functions of 













methods such as 




Dried blood spotting  dp-ucMGP available 
on auto-analyzer as 
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Table 3: Markers and methods for status determination of minerals; for details cf. the respective section in the text. 
 
Fe Cu Zn Se I Mn 
Best marker Serum ferritin Ceruloplasmin, 
serum Cu 
Serum/plasma Zn Plasma Se 
Selenoprotein P 
UI  Serum Mn 




AAS AAS, ICP-MS 
Immunoassay 
Photometric ICP-MS 
















250 µg iodine / g 
creatine (urinary I) 
0.57±0.13 ng/mL 
(serum Mn) 













Previous intake of 
iodine-containing 
food 








Validation of new 
biomarkers (e.g., 
hepcidin-25)  







                                                          
5 Concentrations for initial guidance, not meant as reference range4. 
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2-Pyr  N-Methyl-2-pyridone-5-carboxamide 
4-Py  N-Methyl-4-pyridone-5-carboxamide 
ACP  Acyl carrier protein 
AThTP  Adenosine thiamin triphosphate 
BMI  Body mass index 
CCO  Cytochrome c oxidase 
CoA  Coenzyme A 
Cp  Ceruloplasmin 
CSS  Chaperone for superoxide dismutase 
DBS  Dried blood spot 
DEQAS  Vitamin D External Quality Scheme 
DMT1  Divalent metal transport protein 1 
DNA  Desoxyribonucleic acid 
dp-ucMGP  Desphospho-uncarboxylated matrix Gla-protein 
DRV Dietary reference values  
DTT  Dithiothreitol 
EGRac  Erythrocyte glutathione reductase activity coefficient 
ELISA  Enzyme linked immuno sorbent assay 
ETKA  Erythrocyte transketolase activity 
ETKac Erythrocyte transketolase activity coefficient 
FAD  Flavin adenine dinucleotide 
FDA  Food & Drug Administration 
FMN  Flavin mononucleotide 
FPN1  Ferroportin 1 
GC  Gas chromatography 
GGCX  γ-Glutamate carboxylase 
GH Growth hormone 
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Gla  γ-Carboxyglutamate 
GPx Glutathione peroxidase 
GR  Glutathione reductase 
HAA  3-hydroxyanthranilic acid 
HC  Haptocorrin 
HCP1  Heme carrier protein 1 
Hcy  Homocysteine 
HK  3-Hydroxykynurenine 
holoTC  Holotranscobalamin 
HPLC  High performance liquid chromatography 
HPLC-MS/MS  High performance liquid chromatography tandem mass spectrometry 
HSA  Human serum albumin 
ICP-MS  Inductively-coupled plasma mass spectrometry 
ICP-MS/MS  Inductively-coupled plasma coupled to tandem mass spectrometry 
ICP-OES Inductively-coupled plasma optical emission spectroscopyK2EDTA 
 Ethylenediaminetetraacetic acid potassium salt 
LC-MS/MS  Liquid chromatography coupled to tandem mass spectrometry 
MMA  Methylmalonic acid 
MNAM  N1-Methyl nicotinamide 
MOPD Macular pigment optical density 
MS  Mass spectrometry 
MTHFR  Methylenetetrahydrofolate reductase 
NA  Nicotinic acid 
NAM  Nicotinamide 
NAMO. Nicotinamide-N-oxide 
NIS  Sodium-iodide symporter 
NIST  National Institute of Standards and Technology 
NUA  Nicotinuric acid 
PA 4-Pyridoxic acid 
290118 revised submission TrAC 
~ 43 ~ 
 
PAr  PA:(PLP + PL) ratio 
PIVKA  Descarboxy-prothrombin 
PL  Pyridoxal 
PLP  Pyridoxal 5´-phosphate 
PM  Pyridoxamine 
PMP  Pyridoxamine 5´-phosphate 
PNP  Pyridoxine 5´-phosphate 
PPO  Pyridoxine phosphate oxidase 
RBC Red blood cell 
RDA  Recommended daily allowancesRIA  Radioimmunoassy 
RID  Retinol isotope dilution technique 
SePP  Selenoprotein P 
SFC  Supercritical fluid chromatography 
SOD  Superoxide dismutase 
 
sTfR  Soluble transferrin receptor 
T3  Thyroid hormone triiodothyronine 
T4  Thyroid hormone thyroxine 
TC  Transcobalamin 
TCEP Tris(2-carboxyethyl)phosphine 
TDP  Thiamine diphosphate 
Tg  Thyroglobulin 
THF  Tetrahydrofolate 
TK  Transketolase 
TMP  Thiamine monophosphate 
TSH  Thyroid-stimulating hormone 
TTP  Thiamine triphosphate 
ucOC  Uncarboxylated osteocalcin 
UI Urinary iodine 
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UPLC Ultra-performance liquid chromatography 
VAMS Volumetric absorptive microsampling 
XA  Xanthurenic acid 
α-CEHC  α-Carboxyethyl hydroxychroman 
 
